Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Syndax Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | 2015 Omnibus Incentive Plan (Common Stock, $0.0001 par value per share) | Rule 457(c) and 457(h) | 2,724,455(2) | $24.38(6) | $66,422,212.90(6) | $110.20 per $1,000,000 | $7,319.73 |
Equity | 2015 Employee Stock Purchase Plan (Common Stock, $0.0001 par value per share) | Rule 457(c) and 457(h) | 250,000(3) | $20.72(7) | $5,180,000(7) | $110.20 per $1,000,000 | $570.84 |
Equity | 2023 Inducement Plan (Common Stock, $0.0001 par value per share) | Rule 457(c) and 457(h) | 1,900,000(4) | $24.38(6) | $46,322,000(6) | $110.20 per $1,000,000 | $5,104.68 |
Equity | Inducement Stock Option Grant (Common Stock, $0.0001 par value per share) | Rule 457(h) | 180,000(5) | $16.06(8) | $2,890,800(8) | $110.20 per $1,000,000 | $318.57 |
Equity | Inducement Stock Option Grant (Common Stock, $0.0001 par value per share) | Rule 457(h) | 230,000(5) | $15.60(8) | $3,588,000(8) | $110.20 per $1,000,000 | $395.40 |
Equity | Inducement Stock Option Grant (Common Stock, $0.0001 par value per share) | Rule 457(h) | 220,000(5) | $25.44(8) | $5,596,800(8) | $110.20 per $1,000,000 | $616.77 |
Total Offering Amounts |
| $129,999,812.90 |
| $14,325.99 | |||
Total Fee Offsets |
|
|
| — | |||
Net Fee Due |
|
|
| $14,325.99 |